Product
Viread
1 clinical trial
3 indications
Indication
Hepatitis BIndication
ChronicIndication
Hepatitis DClinical trial
A Phase 2A Randomized, Double-blinded, Placebo-controlled, Multicenter, Dose Ranging Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus CoinfectionStatus: Terminated, Estimated PCD: 2022-09-01